Tate & Lyle stock
Price history
+51.12% over the period1 year: from 367.60 GBp (November 20, 2025) to 555.50 GBp (November 20, 2026), +51.12%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | 555.50 GBp |
| October 30, 2026 | 563.00 GBp |
| September 30, 2026 | 559.00 GBp |
| August 28, 2026 | 554.00 GBp |
| July 31, 2026 | 554.00 GBp |
| June 30, 2026 | 554.00 GBp |
| May 29, 2026 | 505.00 GBp |
| April 30, 2026 | 367.10 GBp |
| March 31, 2026 | 362.00 GBp |
| February 27, 2026 | 376.60 GBp |
| January 30, 2026 | 376.60 GBp |
| December 31, 2025 | 374.80 GBp |
| November 28, 2025 | 374.60 GBp |
| November 20, 2025 | 367.60 GBp |
At a glance
The company
Produce ingredients and solutions including sweeteners, fibres, stabilisers, hydrocolloids, starches, proteins and functional flours for food, beverage and industrial applications
Latest results
Quarter to September 30, 2026 · EPS £0.18 (estimate £0.21)
TickerLandia's take on Tate & Lyle
- Pricier than usual relative to earnings: P/E on the latest fiscal year 26 vs a median of 18 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 37 vs 20 (+85%) in a group of 10.
- Strong point: Dividend (83/100 in its group). Weak point: Growth (38/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−4.22% from the 52-week high
Analysts · 9 analysts
Average target550.78 GBp−0.85% vs. price
Buy 0 · Hold 8 · Sell 1 · Hold
TickerLandia Fingerprint: Tate & Lyle
Compared with similar companies: very high dividend and very low risk.
Financials and price compared with 58 companies in the packaged foods industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Priceaverage49
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 37.0 80 Forward P/E 13.4 40 Price/book 1.57 31 Price/sales 1.22 59 EV/EBITDA 8.82 34 Profitabilityaverage48
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 46.2% 87 ROA 4.0% 27 ROE 4.4% 22 Net margin 3.4% 37 Operating margin 11.6% 65 Earnings stabilityaverage56
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.2% 51 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 61 Growthlow38
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +1.50% 39 Earnings growth (year over year) −49.60% 16 Average revenue growth (3 years) +4.64% 58 Financial strengthaverage49
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 2.40 36 Current ratio 2.84 92 Interest coverage 4.55 34 Debt/equitycounts in reverse: lower means more financial strength 0.84 34 Dividendvery high83
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratiopays out more than its earnings 133.3% 89 Consecutive dividend years 35 years 90 Dividend yield 3.6% 69 Market momentumstrong76
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +4.17% 60 Relative strength (6 months) +7.30% 68 1-year return +51.12% 91 Distance from 200-day average +13.05% 86 Riskvery low18
How much the price swings.
Metric Value Position in group Beta (1 year) 0.47 25 Volatility (60 days) 3.7% 1 Maximum drawdown (12 months) 19.1% 28
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Tate & Lyle is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2026), Tate & Lyle's P/E today is 25.6, above the median of its last 10 fiscal years (17.7; between 9.71 and 133.1 from 2017 to 2026). Tate & Lyle's P/E (trailing 12 months): 37.0, +85% against the median of a group of 10 similar companies (20.0).
Compared with 10 similar companies
| Metric | Tate & Lyle | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 37.0 | High | |
| Forward P/E | 13.4 | Middle | |
| Operating margin | 11.6% | High | |
| ROE | 4.4% | Low | |
| Debt/equity | 0.84 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Tate & Lyle. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
£1.04B
Latest quarter · Q3 2026
Net income
£28M
Latest quarter · Q3 2026
Quarterly net margin
2.7%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- £2.46B
- P/E
- 37.0
- EPS
- 15.00 GBp
- Volume
- 461.01K
- Daily trading
- €11.49M
- Dividend yield
- 3.60%
- Last ex-dividend on November 19, 2026
How Tate & Lyle is changing
All resultsRevenue grew 10.6% a year on average over the last 5 years
Free cash flow equal to 63% of net income
Shares outstanding up 11.1% in 5 years
Returns
Tate & Lyle returns with dividends
£1,000 invested in Tate & Lyle 5 years ago, on November 22, 2021, would be worth £961 today with dividends reinvested: −3.94% in total, −0.80% per year. On price alone it would be £712 (−28.76%).
| Period | Tate & Lyle | FTSE 100 | £1,000 becomes |
|---|---|---|---|
| 1 month | −1.86% | −3.60% | £981 |
| 6 months | +6.42% | −0.82% | £1,064 |
| Year to date | +48.21% | +4.18% | £1,482 |
| 1 year | +56.61% | +8.59% | £1,566 |
| 3 years | +0.01% | +38.02% | £1,000 |
| 5 years | −3.94% | +42.60% | £961 |
| 10 years | +15.48% | +52.65% | £1,155 |
Over the last 6 months it has done better than 50% of the stocks in the Consumer sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. FTSE 100: price only. Calculate your investment
The chart in detail
Tate & Lyle: technical analysis
Tate & Lyle shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 46.1% below its highest close since January 1, 1990 (1,030.17 GBp, July 11, 2013).
- Trend
- No clear trend
- RSI (14 sessions)
- 33
- Between 30 and 70
- vs 200-session average
- +13.05%
Support and resistance
Price areas where Tate & Lyle has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance579.75 GBp+4.37%2 touches, last on June 19, 2026
- Resistance563.50 GBp+1.44%5 touches, last on October 23, 2026
- Last price555.50 GBp
- Support553.21 GBp−0.41%12 touches, last on November 2, 2026
- Support412.40 GBp−25.76%2 touches, last on February 24, 2026
- Support385.60 GBp−30.59%2 touches, last on December 31, 2025
Volatility and risk
Over the last year it has moved less than the FTSE 100.
- Beta (1 year) vs FTSE 100
- 0.47
- Volatility (60 sessions, annualised)
- 3.7%
- Largest fall in the last year
- −19.11%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Tate & Lyle: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Tate & Lyle has been November: +3.31% on average, positive in 24 years out of 36. The weakest has been September: −2.78% on average, positive in 16 years out of 37.
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.94% | +0.86% | 19 of 36 |
| February | +0.27% | +0.95% | 19 of 37 |
| March | −0.45% | +0.34% | 19 of 37 |
| April | +1.31% | +1.72% | 22 of 37 |
| May | +0.88% | −1.96% | 15 of 37 |
| June | −0.10% | −0.86% | 17 of 37 |
| July | +0.52% | +1.31% | 22 of 37 |
| August | +0.75% | −0.51% | 16 of 37 |
| September | −2.78% | −1.77% | 16 of 37 |
| October | +1.57% | +2.14% | 24 of 37 |
| November | +3.31% | +3.42% | 24 of 36 |
| December | +0.43% | +1.50% | 22 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Tate & Lyle and its competitors
Ingredients and solutions for food and beverage makers form the core of the business of Tate & Lyle PLC, which supplies sweeteners, fibres, stabilisers, hydrocolloids, starches, proteins and functional flours. Its customers are manufacturers in beverages, dairy, bakery and snacks, confectionery, soups and sauces, meat and seafood, as well as clinical nutrition, household, industrial and personal care applications. Sales are made across North America, Asia, the Middle East, Africa, Latin America and Europe. The company also has a strategic collaboration with BioHarvest Sciences Inc., and it was incorporated in 1903.
- Headquarters
- London, United Kingdom
- Employees
- 4,840
- Founded
- 1903
- Chief executive
- Anthony Nicholas Hampton
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Tate & LyleTATE | $3.23B | 11.6% | 37.0 | +6.42% |
| Ebro FoodsEBRO | $3.01B | 9.7% | 12.4 | −0.56% |
| Lerøy Seafood GroupLSG | $2.69B | 4.8% | 35.0 | −3.87% |
| AAK AB (publ.)AAK | $4.33B | 10.5% | 12.6 | −33.33% |
| SuedzuckerSZU | $2.39B | 3.5% | — | −8.83% |
| GlanbiaGL9 | $5.11B | 9.6% | 23.2 | −6.37% |
Same industry or related industries, similar size. Compare Tate & Lyle with its competitors · Full profile
